• Mashup Score: 3

    The first experimental pill to fight the virus that causes COVID-19 is on the way, according to the drug company Merck & Co. We hear from Dr. Lynora Saxinger, an infectious diseases specialist at the University of Alberta in Edmonton, about the new drug, molnupiravir, and other COVID-19 treatments.

    Tweet Tweets with this article
    • The Dose - What’s the latest in treatments for COVID-19? https://t.co/0MsJPY2ezo @AntibioticDoc and I wax sceptical about #Molnupinavir. Not because it doesn't work but because there are lots of unanswered questions and no peer reviewed data yet. @cbcpodcasts #TheDoseCBC.